Genmab — September 2020
-
I receive Symphony Health data from pharma- og biotech investors. I dont know anything about af a evnt. split in Dara IV and Dara Faspro.
-
Yes.
-
could use some help on the translation of this chinese article on Amivantamab... https://med.sina.cn/article_detail_103_2_89109.html
-
Sent you a PM E L.
-
That didn't go to well
Hang on - will send you another one. -
I used Google myself (thought you had issued with their translator), but I just asked a Chinese colleague that question, and she said that they are saying that they have permission.
-
Yes.
-
No problem. She is quite impressed that a Dutch guy who doesn't speak Chinese found that article
-
-
Just elaborating after she had a second look. it says that the company got persmission from the government to perform the trials. It basically means that the company must have submitted the request to the government bureau beforehand.
-
Big market if they don't copy it
-
the french estimate a maximum of 7,900 Dara patients in the SC reimbursement document
https://www.has-sante.fr/upload/docs/evamed/CT-18673_DARZALEX_PIC_INS_AvisDef_CT18673.pdf pdf p43
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind